Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy

References

• Pelaia G, Vatrella A, Gallelli L, Cazzola M, Maselli R, Marsico SA. Potential genetic influences on the response to asthma treatment. Pulm Pharmacol Ther. 2004;17(5):253–261. doi:10.1016/j.pupt.2004.04.00515477120
   PubMed Web of Science ®Google Scholar
• Rogers AJ, Tantisira KG, Fuhlbrigge AL, et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics. 2009;10(8):1231–1242. doi:10.2217/pgs.09.8619663668
   PubMed Web of Science ®Google Scholar
• Shastry BS. Genetic diversity and new therapeutic concepts. J Hum Genet. 2005;50(7):321–328. doi:10.1007/s10038-005-0264-616041496
   PubMed Web of Science ®Google Scholar
• Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233–247. doi:10.1038/nri.2017.128192415
   PubMed Web of Science ®Google Scholar
• Strehl C, Buttgereit F. Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol. 2013;380(1–2):32–40. doi:10.1016/j.mce.2013.01.02623403055
   PubMed Web of Science ®Google Scholar
• Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004;53(4):125–132. doi:10.1007/s00011-003-1235-z15060718
   PubMed Web of Science ®Google Scholar
• De Bosscher K, Haegeman G. Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol. 2009;23(3):281–291. doi:10.1210/me.2008-028319095768
   PubMed Web of Science ®Google Scholar
• Perretti M, D’Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1):62–70. doi:10.1038/nri247019104500
   PubMed Web of Science ®Google Scholar
• Girol AP, Mimura KK, Drewes CC, et al. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro. J Immunol. 2013;190(11):5689–5701. doi:10.4049/jimmunol.120203023645879
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010;120(2–3):76–85. doi:10.1016/j.jsbmb.2010.02.01820188830
   PubMed Web of Science ®Google Scholar
• Cazzola M, Coppola A, Rogliani P, Matera MG. Novel glucocorticoid receptor agonists in the treatment of asthma. Expert Opin Investig Drugs. 2015;24(11):1473–1482. doi:10.1517/13543784.2015.1078310
   PubMed Web of Science ®Google Scholar
• Keskin O, Farzan N, Birben E, et al. Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review. Clin Transl Allergy. 2019;9:2. doi:10.1186/s13601-018-0239-230647901
   PubMed Web of Science ®Google Scholar
• Matera MG, Rinaldi B, Calzetta L, Cazzola M. Pharmacogenetic and pharmacogenomic considerations of asthma treatment. Expert Opin Drug Metab Toxicol. 2017;13(11):1159–1167. doi:10.1080/17425255.2017.139121528992739
   PubMed Web of Science ®Google Scholar
• Ortega VE, Bleecker ER. The pharmacogenetics of asthma and the road to personalized medicine. Pulmão RJ. 2012;21(2):41–52.
   Google Scholar
• Duong-Thi-Ly H, Nguyen-Thi-Thu H, Nguyen-Hoang L, Nguyen-Thi-Bich H, Craig TJ, Duong-Quy S. Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review. J Int Med Res. 2017;45(6):1818–1830. doi:10.1177/030006051668387729251255
   PubMed Web of Science ®Google Scholar
• Song QQ, Xie WY, Tang YJ, Zhang J, Liu J. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment. Pharmacogenomics. 2017;18(3):293–316. doi:10.2217/pgs-2016-015128112586
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet. 2004;13(13):1353–1359. doi:10.1093/hmg/ddh14915128701
   PubMed Web of Science ®Google Scholar
• Kim WJ, Sheen SS, Kim TH, et al. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology. 2009;14(2):260–263. doi:10.1111/j.1440-1843.2008.01425.x19210659
   PubMed Web of Science ®Google Scholar
• Awasthi S, Gupta S, Agarwal S, Sharma N. CRHR1 Gene SNPs and response to systemic corticosteroids in Indian asthmatic children during acute exacerbation. Indian J Pediatr. 2015;82(9):781–786. doi:10.1007/s12098-015-1702-x25712009
   PubMed Web of Science ®Google Scholar
• Mougey EB, Chen C, Tantisira KG, et al. Pharmacogenetics of asthma controller treatment. Pharmacogenomics J. 2013;13(3):242–250. doi:10.1038/tpj.2012.522370858
   PubMed Web of Science ®Google Scholar
• Dijkstra A, Koppelman GH, Vonk JM, Bruinenberg M, Schouten JP, Postma DS. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms. J Allergy Clin Immunol. 2008;121(6):1510–1513. doi:10.1016/j.jaci.2008.04.01518539200
   PubMed Web of Science ®Google Scholar
• Keskin O, Uluca Ü, Birben E, et al. Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. Pediatr Allergy Immunol. 2016;27(5):507–513. doi:10.1111/pai.1256627003716
   PubMed Web of Science ®Google Scholar
• Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117(3):522–543. doi:10.1016/j.jaci.2006.01.03216522450
   PubMed Web of Science ®Google Scholar
• Rivers C, Levy A, Hancock J, Lightman S, Norman M. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab. 1999;84(11):4283–4286. doi:10.1210/jcem.84.11.623510566686
   PubMed Web of Science ®Google Scholar
• Lu NZ, Cidlowski JA. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 2006;16(6):301–307. doi:10.1016/j.tcb.2006.04.00516697199
   PubMed Web of Science ®Google Scholar
• Panek M, Pietras T, Fabijan A, et al. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp Ther Med. 2013;5(2):572–580. doi:10.3892/etm.2012.80923407653
   PubMed Web of Science ®Google Scholar
• Leventhal SM, Lim D, Green TL, Cantrell AE, Cho K, Greenhalgh DG. Uncovering a multitude of human glucocorticoid receptor variants: an expansive survey of a single gene. BMC Genet. 2019;20(1):16. doi:10.1186/s12863-019-0718-z30736733
   PubMed Web of Science ®Google Scholar
• Maltese P, Canestrari E, Palma L, et al. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene. J Steroid Biochem Mol Biol. 2009;113(3–5):269–274. doi:10.1016/j.jsbmb.2009.01.01219429432
   PubMed Web of Science ®Google Scholar
• Reimondo G, Chiodini I, Puglisi S, et al. Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas. PLoS One. 2016;11(9):e0162437. doi:10.1371/journal.pone.016243727649075
   PubMed Web of Science ®Google Scholar
• Russcher H, van Rossum EF, de Jong FH, Brinkmann AO, Lamberts SW, Koper JW. Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Mol Endocrinol. 2005;19(7):1687–1696. doi:10.1210/me.2004-046715746190
   PubMedGoogle Scholar
• Cuzzoni E, De Iudicibus S, Bartoli F, Ventura A, Decorti G. Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br J Clin Pharmacol. 2012;73(4):651–655. doi:10.1111/j.1365-2125.2011.04130.x22008062
   PubMed Web of Science ®Google Scholar
• Pietras T, Panek M, Tworek D, et al. The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep. 2011;38(6):3953–3958. doi:10.1007/s11033-010-0512-521113676
   PubMed Web of Science ®Google Scholar
• Huizenga NA, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83(1):144–151. doi:10.1210/jcem.83.1.44909435432
   PubMed Web of Science ®Google Scholar
• Jewell CM, Cidlowski JA. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J Clin Endocrinol Metab. 2007;92(8):3268–3277. doi:10.1210/jc.2007-064217535992
   PubMed Web of Science ®Google Scholar
• Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010;75(1):1–12. doi:10.1016/j.steroids.2009.09.00219818358
   PubMed Web of Science ®Google Scholar
• Panek M, Pietras T, Antczak A, Górski P, Kuna P, Szemraj J. The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthma. Mol Biol Rep. 2012;39(4):4749–4757. doi:10.1007/s11033-011-1267-322015776
   PubMed Web of Science ®Google Scholar
• Szczepankiewicz A, Breborowicz A, Sobkowiak P, Popiel A. No association of glucocorticoid receptor polymorphisms with asthma and response to glucocorticoids. Adv Med Sci. 2008;53(2):245–250. doi:10.2478/v10039-008-0042-818952539
   PubMed Web of Science ®Google Scholar
• Koper JW, Stolk RP, de Lange P, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997;99(5):663–668. doi:10.1007/s0043900504259150737
   PubMed Web of Science ®Google Scholar
• Huizenga NA, de Lange P, Koper JW, et al. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab. 2000;85(5):2076–2081. doi:10.1210/jcem.85.5.654210843199
   PubMed Web of Science ®Google Scholar
• Green TL, Tung K, Lim D, Leventhal SM, Cho K, Greenhalgh DG. A novel human glucocorticoid receptor SNP results in increased transactivation potential. Biochem Biophys Rep. 2016;9:140–145. doi:10.1016/j.bbrep.2016.12.00328955999
   PubMedGoogle Scholar
• Hawkins GA, Lazarus R, Smith RS, et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol. 2009;123(6):1376–1383. doi:10.1016/j.jaci.2009.01.04919254810
   PubMed Web of Science ®Google Scholar
• Ouyang J, Chen P, Jiang T, Chen Y, Li J. Nuclear HSP90 regulates the glucocorticoid responsiveness of PBMCs in patients with idiopathic nephrotic syndrome. Int Immunopharmacol. 2012;14(3):334–340. doi:10.1016/j.intimp.2012.08.01222926076
   PubMed Web of Science ®Google Scholar
• Maltese P, Palma L, Sfara C, et al. Glucocorticoid resistance in Crohn’s disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms. Pharmacogenomics J. 2012;12(5):432–438. doi:10.1038/tpj.2011.2621788965
   PubMed Web of Science ®Google Scholar
• Koper JW, van Rossum EF, van den Akker EL. Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids. 2014;92:62–73. doi:10.1016/j.steroids.2014.07.01525150015
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Mercado N, Barnes PJ, Ito K, Hartl D. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma. PLoS One. 2011;6(12):e27627. doi:10.1371/journal.pone.002762722205926
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Ito K, Kanda A, Tomoda K, Mercado N, Barnes PJ. Impaired dual-specificity protein phosphatase DUSP4 reduces corticosteroid sensitivity. Mol Pharmacol. 2017;91(5):475–481. doi:10.1124/mol.116.10765628283554
   PubMed Web of Science ®Google Scholar
• Pelaia G, Cuda G, Vatrella A, et al. Mitogen-activated protein kinases and asthma. J Cell Physiol. 2005;202(3):642–653. doi:10.1002/jcp.2016915316926
   PubMed Web of Science ®Google Scholar
• Wang X, Nelin LD, Kuhlman JR, Meng X, Welty SE, Liu Y. The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci. 2008;83(19–20):671–680. doi:10.1016/j.lfs.2008.09.00318845168
   PubMed Web of Science ®Google Scholar
• Jin Y, Hu D, Peterson EL, et al. Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients. J Allergy Clin Immunol. 2010;126(3):618–625. doi:10.1016/j.jaci.2010.06.00720673984
   PubMed Web of Science ®Google Scholar
• Shaw D, Portelli MA, Sayers I. Asthma In: Padmanabhan S, editor. Handbook of Pharmacogenomics and Stratified Medicine. London: Academic Press; 2014.
   Google Scholar
• Bhavsar P, Ahmad T, Adcock IM. The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol. 2008;121(3):580–584. doi:10.1016/j.jaci.2007.12.115618234319
   PubMed Web of Science ®Google Scholar
• Grausenburger R, Bilic I, Boucheron N, et al. Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J Immunol. 2010;185(6):3489–3497. doi:10.4049/jimmunol.090361020702731
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Therapy of airway disease: epigenetic potential In: Tollefsbol T, editor. Epigenetics in Human Disease. Amsterdam: Elsevier; 2012:387–393.
   Google Scholar
• Kim MH, Kim SH, Kim YK, et al. A polymorphism in the histone deacetylase 1 gene is associated with the response to corticosteroids in asthmatics. Korean J Intern Med. 2013;28(6):708–714. doi:10.3904/kjim.2013.28.6.70824307847
   PubMed Web of Science ®Google Scholar
• Matera MG, Rinaldi B, Calzetta L, Rogliani P, Cazzola M. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment. Pulm Pharmacol Ther. 2019;58:101828. doi:10.1016/j.pupt.2019.10182831349002
   PubMed Web of Science ®Google Scholar
• Kelly HW. Comparison of inhaled corticosteroids: an update. Ann Pharmacother. 2009;43(3):519–527. doi:10.1345/aph.1L54619261959
   PubMed Web of Science ®Google Scholar
• Stockmann C, Fassl B, Gaedigk R, et al. Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. J Pediatr. 2013;162(6):1222–1227. doi:10.1016/j.jpeds.2012.11.03123290512
   PubMed Web of Science ®Google Scholar
• Stockmann C, Reilly CA, Fassl B, et al. Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone. J Allergy Clin Immunol. 2015;136(2):505–507. doi:10.1016/j.jaci.2015.02.00925825214
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905–1917. doi:10.1016/S0140-6736(09)60326-319482216
   PubMed Web of Science ®Google Scholar
• Han SS, Xu YQ, Lu Y, Gu XC, Wang Y. A PRISM: a-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: susceptibility and steroid responsiveness. Medicine (Baltimore). 2017;96(24):e7191. doi:10.1097/MD.000000000000719128614261
   PubMed Web of Science ®Google Scholar
• Crowe A, Tan AM. Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux. Toxicol Appl Pharmacol. 2012;260(3):294–302. doi:10.1016/j.taap.2012.03.00822464980
   PubMed Web of Science ®Google Scholar
• Vandevyver S, Dejager L, Libert C. On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic. 2012;13(3):364–374. doi:10.1111/j.1600-0854.2011.01288.x21951602
   PubMed Web of Science ®Google Scholar
• Mingot JM, Kostka S, Kraft R, Hartmann E, Görlich D. Importin 13: a novel mediator of nuclear import and export. EMBO J. 2001;20(14):3685–3694. doi:10.1093/emboj/20.14.368511447110
   PubMed Web of Science ®Google Scholar
• Tao T, Lan J, Lukacs GL, Haché RJ, Kaplan F. Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. Am J Respir Cell Mol Biol. 2006;35(6):668–680. doi:10.1165/rcmb.2006-0073OC16809634
   PubMed Web of Science ®Google Scholar
• Raby BA, Van Steen K, Lasky-Su J, Tantisira K, Kaplan F, Weiss ST. Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma. Respir Res. 2009;10(1):67. doi:10.1186/1465-9921-10-6719619331
   PubMed Web of Science ®Google Scholar
• Turolo S, Edefonti A, Lepore M, et al. SXR rs3842689: a prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome. Pharmacogenomics. 2016;17(11):1227–1233. doi:10.2217/pgs-2016-002927377607
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci USA. 2004;101(52):18099–18104. doi:10.1073/pnas.040853210215604153
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Lasky-Su J, Harada M, et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med. 2011;365(13):1173–1183. doi:10.1056/NEJMoa091135321991891
   PubMed Web of Science ®Google Scholar
• Chapman MS, Qu N, Pascoe S, et al. Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol Cell Endocrinol. 1995;108(1–2):R1–R7. doi:10.1016/0303-7207(95)03481-L7758820
   PubMed Web of Science ®Google Scholar
• Hosking L, Bleecker E, Ghosh S, et al. GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma. J Allergy Clin Immunol. 2014;133(2):587–589. doi:10.1016/j.jaci.2013.08.02424131825
   PubMed Web of Science ®Google Scholar
• Hu CP, Xun QF, Li XZ, et al. Effects of glucocorticoid-induced transcript 1 gene deficiency on glucocorticoid activation in asthmatic mice. Chin Med J (Engl). 2018;131(23):2817–2826. doi:10.4103/0366-6999.24606130511684
   PubMed Web of Science ®Google Scholar
• Park HW, Dahlin A, Tse S, et al. Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids. J Allergy Clin Immunol. 2014;133(3):664–669. doi:10.1016/j.jaci.2013.12.104224486069
   PubMed Web of Science ®Google Scholar
• Gautam Y, Afanador Y, Abebe T, López JE, Mersha TB. Genome-wide analysis revealed sex-specific gene expression in asthmatics. Hum Mol Genet. 2019;28(15):2600–2614. doi:10.1093/hmg/ddz074
   PubMed Web of Science ®Google Scholar
• Berce V, Kozmus CE, Potočnik U. Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma. Pharmacogenomics J. 2013;13(6):523–529. doi:10.1038/tpj.2012.3622986918
   PubMed Web of Science ®Google Scholar
• Leusink M, Vijverberg SJ, Koenderman L, et al. Genetic variation in uncontrolled childhood asthma despite ICS treatment. Pharmacogenomics J. 2016;16(2):158–163. doi:10.1038/tpj.2015.3625963336
   PubMed Web of Science ®Google Scholar
• Ryan JJ, Spiegel S. The role of sphingosine-1-phosphate and its receptors in asthma. Drug News Perspect. 2008;21(2):89–96. doi:10.1358/dnp.2008.21.2.118819518389100
   PubMedGoogle Scholar
• Balantic M, Rijavec M, Skerbinjek Kavalar M, et al. Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms. Mol Diagn Ther. 2012;16(3):173–180. doi:10.1007/BF0326220622519966
   PubMed Web of Science ®Google Scholar
• Lee KS, Kim SR, Park HS, Jin GY, Lee YC. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol. 2004;114(5):1093–1099. doi:10.1016/j.jaci.2004.07.03915536415
   PubMed Web of Science ®Google Scholar
• García-Menaya JM, Cordobés-Durán C, García-Martín E, Agúndez JAG. Pharmacogenetic factors affecting asthma treatment response. Potential implications for drug therapy. Front Pharmacol. 2019;10:520. doi:10.3389/fphar.2019.0052031178722
   PubMed Web of Science ®Google Scholar
• Wang RS, Croteau-Chonka DC, Silverman EK, Loscalzo J, Weiss ST, Hall KT. Pharmacogenomics and placebo response in a randomized clinical trial in asthma. Clin Pharmacol Ther. 2019;106(6):1261–1267. doi:10.1002/cpt.164631557306
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Silverman ES, Mariani TJ, et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol. 2007;120(6):1285–1291. doi:10.1016/j.jaci.2007.09.00517980418
   PubMed Web of Science ®Google Scholar
• Koster ES, Maitland-van der Zee A-H, Tavendale R, Maitland-van der Zee AH, Tavendale R, et al. FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children. Allergy. 2011;66(12):1546–1552. doi:10.1111/j.1398-9995.2011.02701.x21958076
   PubMed Web of Science ®Google Scholar
• Farzan N, Vijverberg SJ, Arets HG, Raaijmakers JA, Maitland-van der Zee AH. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review. Clin Exp Allergy. 2017;47(2):271–293. doi:10.1111/cea.1284427790783
   PubMed Web of Science ®Google Scholar
• Mosteller M, Hosking L, Murphy K, et al. No evidence of large genetic effects on steroid response in asthma patients. J Allergy Clin Immunol. 2017;139(3):797–803. doi:10.1016/j.jaci.2016.05.03227523435
   PubMed Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani P. How does race/ethnicity influence pharmacological response to asthma therapies? Expert Opin Drug Metab Toxicol. 2018;14(4):435–446. doi:10.1080/17425255.2018.144983329528249
   PubMed Web of Science ®Google Scholar
• Hernandez-Pacheco N, Farzan N, Francis B, et al. Genome-wide association study of inhaled corticosteroid response in admixed children with asthma. Clin Exp Allergy. 2019;49(6):789–798. doi:10.1111/cea.1335430697902
   PubMed Web of Science ®Google Scholar
• Wells KE, Cajigal S, Peterson EL, et al. Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects. J Allergy Clin Immunol. 2016;137(5):1364–1369. doi:10.1016/j.jaci.2015.12.133427016472
   PubMed Web of Science ®Google Scholar
• Ulrik CS, Vijverberg S, Hanania NA, Diamant Z. Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020;26(1):33–39. doi:10.1097/MCP.000000000000063931644440
   PubMed Web of Science ®Google Scholar
• Kersten ET, Koppelman GH. Pharmacogenetics of asthma: toward precision medicine. Curr Opin Pulm Med. 2017;23(1):12–20. doi:10.1097/MCP.000000000000033527764000
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Bossley C, Gupta A, et al. Passive smoking impairs histone deacetylase-2 in children with severe asthma. Chest. 2014;145(2):305–312. doi:10.1378/chest.13-083524030221
   PubMed Web of Science ®Google Scholar
• Park HW, Tantisira KG, Weiss ST. Pharmacogenomics in asthma therapy: where are we and where do we go? Annu Rev Pharmacol Toxicol. 2015;55:129–147. doi:10.1146/annurev-pharmtox-010814-12454325292431
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz MI, Neerincx AH, Vijverberg SJ, Kraneveld AD, Maitland-van der Zee AH. Omics for the future in asthma. Semin Immunopathol. 2020;42(1):111–126. doi:10.1007/s00281-019-00776-x31942640
   PubMed Web of Science ®Google Scholar